nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0686	0.127	CbGbCtD
Treprostinil—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0628	0.116	CbGbCtD
Treprostinil—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0584	0.108	CbGbCtD
Treprostinil—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0496	0.0916	CbGbCtD
Treprostinil—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0496	0.0916	CbGbCtD
Treprostinil—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0458	0.0845	CbGbCtD
Treprostinil—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0442	0.0816	CbGbCtD
Treprostinil—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0405	0.0747	CbGbCtD
Treprostinil—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0376	0.0694	CbGbCtD
Treprostinil—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0361	0.0665	CbGbCtD
Treprostinil—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0254	0.0469	CbGbCtD
Treprostinil—CYP2C9—Losartan—type 2 diabetes mellitus	0.0232	0.0429	CbGbCtD
Treprostinil—P2RY12—artery—type 2 diabetes mellitus	0.0105	0.21	CbGeAlD
Treprostinil—PTGIR—artery—type 2 diabetes mellitus	0.00669	0.134	CbGeAlD
Treprostinil—PTGIR—endothelium—type 2 diabetes mellitus	0.00565	0.113	CbGeAlD
Treprostinil—PPARD—islet of Langerhans—type 2 diabetes mellitus	0.00419	0.084	CbGeAlD
Treprostinil—P2RY12—cardiovascular system—type 2 diabetes mellitus	0.00365	0.0731	CbGeAlD
Treprostinil—Nadolol—ADRB3—type 2 diabetes mellitus	0.00329	1	CrCbGaD
Treprostinil—PPARD—pancreas—type 2 diabetes mellitus	0.00294	0.059	CbGeAlD
Treprostinil—PPARD—adipose tissue—type 2 diabetes mellitus	0.00267	0.0536	CbGeAlD
Treprostinil—PTGIR—cardiovascular system—type 2 diabetes mellitus	0.00233	0.0466	CbGeAlD
Treprostinil—PTGIR—kidney—type 2 diabetes mellitus	0.00228	0.0456	CbGeAlD
Treprostinil—PTGIR—pancreas—type 2 diabetes mellitus	0.00226	0.0453	CbGeAlD
Treprostinil—PTGIR—adipose tissue—type 2 diabetes mellitus	0.00205	0.0411	CbGeAlD
Treprostinil—PPARD—liver—type 2 diabetes mellitus	0.00187	0.0376	CbGeAlD
Treprostinil—PTGIR—liver—type 2 diabetes mellitus	0.00144	0.0288	CbGeAlD
Treprostinil—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000831	0.0167	CbGeAlD
Treprostinil—CYP2C9—liver—type 2 diabetes mellitus	0.000514	0.0103	CbGeAlD
Treprostinil—Palpitations—Metformin—type 2 diabetes mellitus	0.000236	0.000985	CcSEcCtD
Treprostinil—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000236	0.000983	CcSEcCtD
Treprostinil—Shock—Valsartan—type 2 diabetes mellitus	0.000235	0.000983	CcSEcCtD
Treprostinil—Infection—Orlistat—type 2 diabetes mellitus	0.000235	0.00098	CcSEcCtD
Treprostinil—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000235	0.000979	CcSEcCtD
Treprostinil—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000234	0.000978	CcSEcCtD
Treprostinil—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000234	0.000976	CcSEcCtD
Treprostinil—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000234	0.000976	CcSEcCtD
Treprostinil—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000233	0.000972	CcSEcCtD
Treprostinil—Tension—Losartan—type 2 diabetes mellitus	0.000233	0.000971	CcSEcCtD
Treprostinil—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000233	0.000971	CcSEcCtD
Treprostinil—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000232	0.000969	CcSEcCtD
Treprostinil—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000232	0.000968	CcSEcCtD
Treprostinil—Nervousness—Losartan—type 2 diabetes mellitus	0.00023	0.000961	CcSEcCtD
Treprostinil—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00023	0.000961	CcSEcCtD
Treprostinil—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.00023	0.00096	CcSEcCtD
Treprostinil—Back pain—Losartan—type 2 diabetes mellitus	0.000229	0.000957	CcSEcCtD
Treprostinil—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000229	0.000957	CcSEcCtD
Treprostinil—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000229	0.000957	CcSEcCtD
Treprostinil—Anorexia—Valsartan—type 2 diabetes mellitus	0.000228	0.000952	CcSEcCtD
Treprostinil—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000228	0.000952	CcSEcCtD
Treprostinil—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000228	0.00095	CcSEcCtD
Treprostinil—Chest pain—Metformin—type 2 diabetes mellitus	0.000227	0.000949	CcSEcCtD
Treprostinil—Myalgia—Metformin—type 2 diabetes mellitus	0.000227	0.000949	CcSEcCtD
Treprostinil—Malaise—Irbesartan—type 2 diabetes mellitus	0.000227	0.000948	CcSEcCtD
Treprostinil—Headache—Pioglitazone—type 2 diabetes mellitus	0.000226	0.000944	CcSEcCtD
Treprostinil—Syncope—Irbesartan—type 2 diabetes mellitus	0.000226	0.000943	CcSEcCtD
Treprostinil—Discomfort—Metformin—type 2 diabetes mellitus	0.000225	0.000937	CcSEcCtD
Treprostinil—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000225	0.000937	CcSEcCtD
Treprostinil—Nausea—Glipizide—type 2 diabetes mellitus	0.000224	0.000934	CcSEcCtD
Treprostinil—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000224	0.000933	CcSEcCtD
Treprostinil—Hypotension—Valsartan—type 2 diabetes mellitus	0.000224	0.000933	CcSEcCtD
Treprostinil—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000223	0.00093	CcSEcCtD
Treprostinil—Pain—Gliclazide—type 2 diabetes mellitus	0.000223	0.00093	CcSEcCtD
Treprostinil—Rash—Glimepiride—type 2 diabetes mellitus	0.000222	0.000926	CcSEcCtD
Treprostinil—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000222	0.000925	CcSEcCtD
Treprostinil—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000221	0.000924	CcSEcCtD
Treprostinil—Rash—Sitagliptin—type 2 diabetes mellitus	0.000221	0.000923	CcSEcCtD
Treprostinil—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000221	0.000922	CcSEcCtD
Treprostinil—Headache—Glimepiride—type 2 diabetes mellitus	0.00022	0.00092	CcSEcCtD
Treprostinil—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.00022	0.000918	CcSEcCtD
Treprostinil—Cough—Irbesartan—type 2 diabetes mellitus	0.00022	0.000918	CcSEcCtD
Treprostinil—Headache—Sitagliptin—type 2 diabetes mellitus	0.00022	0.000917	CcSEcCtD
Treprostinil—Anaemia—Losartan—type 2 diabetes mellitus	0.000219	0.000915	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000218	0.00091	CcSEcCtD
Treprostinil—Oedema—Metformin—type 2 diabetes mellitus	0.000218	0.000909	CcSEcCtD
Treprostinil—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000217	0.000906	CcSEcCtD
Treprostinil—Flushing—Ramipril—type 2 diabetes mellitus	0.000217	0.000905	CcSEcCtD
Treprostinil—Angioedema—Losartan—type 2 diabetes mellitus	0.000217	0.000904	CcSEcCtD
Treprostinil—Infection—Metformin—type 2 diabetes mellitus	0.000216	0.000904	CcSEcCtD
Treprostinil—Insomnia—Valsartan—type 2 diabetes mellitus	0.000216	0.000903	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000215	0.000899	CcSEcCtD
Treprostinil—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000215	0.000897	CcSEcCtD
Treprostinil—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000215	0.000896	CcSEcCtD
Treprostinil—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000214	0.000895	CcSEcCtD
Treprostinil—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000214	0.000895	CcSEcCtD
Treprostinil—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000214	0.000895	CcSEcCtD
Treprostinil—Shock—Metformin—type 2 diabetes mellitus	0.000214	0.000895	CcSEcCtD
Treprostinil—Insomnia—Orlistat—type 2 diabetes mellitus	0.000214	0.000893	CcSEcCtD
Treprostinil—Malaise—Losartan—type 2 diabetes mellitus	0.000214	0.000892	CcSEcCtD
Treprostinil—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000214	0.000892	CcSEcCtD
Treprostinil—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000213	0.00089	CcSEcCtD
Treprostinil—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000213	0.00089	CcSEcCtD
Treprostinil—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000213	0.000889	CcSEcCtD
Treprostinil—Syncope—Losartan—type 2 diabetes mellitus	0.000213	0.000888	CcSEcCtD
Treprostinil—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000212	0.000886	CcSEcCtD
Treprostinil—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000212	0.000885	CcSEcCtD
Treprostinil—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000211	0.000879	CcSEcCtD
Treprostinil—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00021	0.000876	CcSEcCtD
Treprostinil—Palpitations—Losartan—type 2 diabetes mellitus	0.00021	0.000875	CcSEcCtD
Treprostinil—Nausea—Glimepiride—type 2 diabetes mellitus	0.000209	0.000872	CcSEcCtD
Treprostinil—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000208	0.00087	CcSEcCtD
Treprostinil—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000208	0.000869	CcSEcCtD
Treprostinil—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000208	0.000869	CcSEcCtD
Treprostinil—Asthenia—Glyburide—type 2 diabetes mellitus	0.000208	0.000869	CcSEcCtD
Treprostinil—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000208	0.000868	CcSEcCtD
Treprostinil—Anorexia—Metformin—type 2 diabetes mellitus	0.000208	0.000867	CcSEcCtD
Treprostinil—Cough—Losartan—type 2 diabetes mellitus	0.000207	0.000864	CcSEcCtD
Treprostinil—Fatigue—Valsartan—type 2 diabetes mellitus	0.000206	0.000861	CcSEcCtD
Treprostinil—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000206	0.000859	CcSEcCtD
Treprostinil—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000206	0.000859	CcSEcCtD
Treprostinil—Oedema—Irbesartan—type 2 diabetes mellitus	0.000206	0.000858	CcSEcCtD
Treprostinil—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000206	0.000858	CcSEcCtD
Treprostinil—Pruritus—Glyburide—type 2 diabetes mellitus	0.000205	0.000856	CcSEcCtD
Treprostinil—Infection—Irbesartan—type 2 diabetes mellitus	0.000204	0.000853	CcSEcCtD
Treprostinil—Fatigue—Orlistat—type 2 diabetes mellitus	0.000204	0.000851	CcSEcCtD
Treprostinil—Hypotension—Metformin—type 2 diabetes mellitus	0.000204	0.00085	CcSEcCtD
Treprostinil—Erythema—Ramipril—type 2 diabetes mellitus	0.000203	0.000849	CcSEcCtD
Treprostinil—Shock—Irbesartan—type 2 diabetes mellitus	0.000202	0.000844	CcSEcCtD
Treprostinil—Pain—Orlistat—type 2 diabetes mellitus	0.000202	0.000844	CcSEcCtD
Treprostinil—Chest pain—Losartan—type 2 diabetes mellitus	0.000202	0.000843	CcSEcCtD
Treprostinil—Myalgia—Losartan—type 2 diabetes mellitus	0.000202	0.000843	CcSEcCtD
Treprostinil—Arthralgia—Losartan—type 2 diabetes mellitus	0.000202	0.000843	CcSEcCtD
Treprostinil—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000202	0.000842	CcSEcCtD
Treprostinil—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000201	0.00084	CcSEcCtD
Treprostinil—Anxiety—Losartan—type 2 diabetes mellitus	0.000201	0.00084	CcSEcCtD
Treprostinil—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000201	0.000838	CcSEcCtD
Treprostinil—Rash—Bromocriptine—type 2 diabetes mellitus	0.0002	0.000835	CcSEcCtD
Treprostinil—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.0002	0.000834	CcSEcCtD
Treprostinil—Tension—Ramipril—type 2 diabetes mellitus	0.000199	0.000833	CcSEcCtD
Treprostinil—Discomfort—Losartan—type 2 diabetes mellitus	0.000199	0.000832	CcSEcCtD
Treprostinil—Headache—Bromocriptine—type 2 diabetes mellitus	0.000199	0.00083	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000199	0.000829	CcSEcCtD
Treprostinil—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000198	0.000828	CcSEcCtD
Treprostinil—Nervousness—Ramipril—type 2 diabetes mellitus	0.000197	0.000824	CcSEcCtD
Treprostinil—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000196	0.000818	CcSEcCtD
Treprostinil—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000196	0.000817	CcSEcCtD
Treprostinil—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000196	0.000817	CcSEcCtD
Treprostinil—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000195	0.000816	CcSEcCtD
Treprostinil—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000195	0.000813	CcSEcCtD
Treprostinil—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000194	0.000811	CcSEcCtD
Treprostinil—Oedema—Losartan—type 2 diabetes mellitus	0.000194	0.000808	CcSEcCtD
Treprostinil—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000193	0.000807	CcSEcCtD
Treprostinil—Infection—Losartan—type 2 diabetes mellitus	0.000192	0.000802	CcSEcCtD
Treprostinil—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000192	0.000802	CcSEcCtD
Treprostinil—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000192	0.000801	CcSEcCtD
Treprostinil—Shock—Losartan—type 2 diabetes mellitus	0.00019	0.000795	CcSEcCtD
Treprostinil—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000189	0.000791	CcSEcCtD
Treprostinil—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000189	0.000791	CcSEcCtD
Treprostinil—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000189	0.000789	CcSEcCtD
Treprostinil—Tachycardia—Losartan—type 2 diabetes mellitus	0.000189	0.000788	CcSEcCtD
Treprostinil—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000189	0.000787	CcSEcCtD
Treprostinil—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000188	0.000787	CcSEcCtD
Treprostinil—Fatigue—Metformin—type 2 diabetes mellitus	0.000188	0.000784	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000187	0.000782	CcSEcCtD
Treprostinil—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000187	0.00078	CcSEcCtD
Treprostinil—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000187	0.00078	CcSEcCtD
Treprostinil—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000187	0.00078	CcSEcCtD
Treprostinil—Angioedema—Ramipril—type 2 diabetes mellitus	0.000186	0.000775	CcSEcCtD
Treprostinil—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000185	0.000771	CcSEcCtD
Treprostinil—Anorexia—Losartan—type 2 diabetes mellitus	0.000184	0.00077	CcSEcCtD
Treprostinil—Vomiting—Glyburide—type 2 diabetes mellitus	0.000184	0.00077	CcSEcCtD
Treprostinil—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000184	0.000769	CcSEcCtD
Treprostinil—Malaise—Ramipril—type 2 diabetes mellitus	0.000183	0.000765	CcSEcCtD
Treprostinil—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000183	0.000765	CcSEcCtD
Treprostinil—Rash—Glyburide—type 2 diabetes mellitus	0.000183	0.000763	CcSEcCtD
Treprostinil—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000183	0.000763	CcSEcCtD
Treprostinil—Syncope—Ramipril—type 2 diabetes mellitus	0.000182	0.000761	CcSEcCtD
Treprostinil—Headache—Glyburide—type 2 diabetes mellitus	0.000182	0.000758	CcSEcCtD
Treprostinil—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000181	0.000755	CcSEcCtD
Treprostinil—Hypotension—Losartan—type 2 diabetes mellitus	0.000181	0.000755	CcSEcCtD
Treprostinil—Palpitations—Ramipril—type 2 diabetes mellitus	0.00018	0.00075	CcSEcCtD
Treprostinil—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00018	0.000749	CcSEcCtD
Treprostinil—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000179	0.000746	CcSEcCtD
Treprostinil—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000179	0.000746	CcSEcCtD
Treprostinil—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000178	0.000744	CcSEcCtD
Treprostinil—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000178	0.000744	CcSEcCtD
Treprostinil—Cough—Ramipril—type 2 diabetes mellitus	0.000177	0.000741	CcSEcCtD
Treprostinil—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000177	0.00074	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000176	0.000736	CcSEcCtD
Treprostinil—Pain—Irbesartan—type 2 diabetes mellitus	0.000176	0.000734	CcSEcCtD
Treprostinil—Insomnia—Losartan—type 2 diabetes mellitus	0.000175	0.000731	CcSEcCtD
Treprostinil—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000174	0.000725	CcSEcCtD
Treprostinil—Chest pain—Ramipril—type 2 diabetes mellitus	0.000173	0.000722	CcSEcCtD
Treprostinil—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000173	0.000722	CcSEcCtD
Treprostinil—Myalgia—Ramipril—type 2 diabetes mellitus	0.000173	0.000722	CcSEcCtD
Treprostinil—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000173	0.00072	CcSEcCtD
Treprostinil—Anxiety—Ramipril—type 2 diabetes mellitus	0.000172	0.00072	CcSEcCtD
Treprostinil—Nausea—Glyburide—type 2 diabetes mellitus	0.000172	0.000719	CcSEcCtD
Treprostinil—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000172	0.000719	CcSEcCtD
Treprostinil—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000172	0.000719	CcSEcCtD
Treprostinil—Asthenia—Valsartan—type 2 diabetes mellitus	0.000172	0.000717	CcSEcCtD
Treprostinil—Discomfort—Ramipril—type 2 diabetes mellitus	0.000171	0.000714	CcSEcCtD
Treprostinil—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00017	0.000711	CcSEcCtD
Treprostinil—Asthenia—Orlistat—type 2 diabetes mellitus	0.00017	0.000708	CcSEcCtD
Treprostinil—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000169	0.000707	CcSEcCtD
Treprostinil—Pruritus—Valsartan—type 2 diabetes mellitus	0.000169	0.000707	CcSEcCtD
Treprostinil—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000168	0.000702	CcSEcCtD
Treprostinil—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000168	0.000702	CcSEcCtD
Treprostinil—Pruritus—Orlistat—type 2 diabetes mellitus	0.000167	0.000698	CcSEcCtD
Treprostinil—Fatigue—Losartan—type 2 diabetes mellitus	0.000167	0.000696	CcSEcCtD
Treprostinil—Oedema—Ramipril—type 2 diabetes mellitus	0.000166	0.000693	CcSEcCtD
Treprostinil—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000166	0.000691	CcSEcCtD
Treprostinil—Pain—Losartan—type 2 diabetes mellitus	0.000165	0.000691	CcSEcCtD
Treprostinil—Rash—Gliclazide—type 2 diabetes mellitus	0.000164	0.000685	CcSEcCtD
Treprostinil—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000164	0.000685	CcSEcCtD
Treprostinil—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000164	0.000683	CcSEcCtD
Treprostinil—Shock—Ramipril—type 2 diabetes mellitus	0.000163	0.000681	CcSEcCtD
Treprostinil—Headache—Gliclazide—type 2 diabetes mellitus	0.000163	0.000681	CcSEcCtD
Treprostinil—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000163	0.000678	CcSEcCtD
Treprostinil—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000163	0.000678	CcSEcCtD
Treprostinil—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000162	0.000678	CcSEcCtD
Treprostinil—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000162	0.000676	CcSEcCtD
Treprostinil—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000162	0.000675	CcSEcCtD
Treprostinil—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000159	0.000666	CcSEcCtD
Treprostinil—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000158	0.00066	CcSEcCtD
Treprostinil—Dizziness—Valsartan—type 2 diabetes mellitus	0.000158	0.00066	CcSEcCtD
Treprostinil—Anorexia—Ramipril—type 2 diabetes mellitus	0.000158	0.00066	CcSEcCtD
Treprostinil—Dizziness—Orlistat—type 2 diabetes mellitus	0.000156	0.000653	CcSEcCtD
Treprostinil—Asthenia—Metformin—type 2 diabetes mellitus	0.000156	0.000653	CcSEcCtD
Treprostinil—Hypotension—Ramipril—type 2 diabetes mellitus	0.000155	0.000647	CcSEcCtD
Treprostinil—Nausea—Gliclazide—type 2 diabetes mellitus	0.000155	0.000646	CcSEcCtD
Treprostinil—Pruritus—Metformin—type 2 diabetes mellitus	0.000154	0.000643	CcSEcCtD
Treprostinil—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000153	0.000639	CcSEcCtD
Treprostinil—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000153	0.000639	CcSEcCtD
Treprostinil—Vomiting—Valsartan—type 2 diabetes mellitus	0.000152	0.000635	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000151	0.000631	CcSEcCtD
Treprostinil—Rash—Valsartan—type 2 diabetes mellitus	0.000151	0.00063	CcSEcCtD
Treprostinil—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000151	0.000629	CcSEcCtD
Treprostinil—Vomiting—Orlistat—type 2 diabetes mellitus	0.00015	0.000627	CcSEcCtD
Treprostinil—Insomnia—Ramipril—type 2 diabetes mellitus	0.00015	0.000626	CcSEcCtD
Treprostinil—Headache—Valsartan—type 2 diabetes mellitus	0.00015	0.000626	CcSEcCtD
Treprostinil—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000149	0.000622	CcSEcCtD
Treprostinil—Rash—Orlistat—type 2 diabetes mellitus	0.000149	0.000622	CcSEcCtD
Treprostinil—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000149	0.000622	CcSEcCtD
Treprostinil—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000149	0.000622	CcSEcCtD
Treprostinil—Headache—Orlistat—type 2 diabetes mellitus	0.000148	0.000618	CcSEcCtD
Treprostinil—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000148	0.000617	CcSEcCtD
Treprostinil—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000148	0.000616	CcSEcCtD
Treprostinil—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000146	0.00061	CcSEcCtD
Treprostinil—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000145	0.000607	CcSEcCtD
Treprostinil—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000144	0.000602	CcSEcCtD
Treprostinil—Dizziness—Metformin—type 2 diabetes mellitus	0.000144	0.000601	CcSEcCtD
Treprostinil—Fatigue—Ramipril—type 2 diabetes mellitus	0.000143	0.000597	CcSEcCtD
Treprostinil—Nausea—Valsartan—type 2 diabetes mellitus	0.000142	0.000593	CcSEcCtD
Treprostinil—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000141	0.000587	CcSEcCtD
Treprostinil—Nausea—Orlistat—type 2 diabetes mellitus	0.00014	0.000586	CcSEcCtD
Treprostinil—Asthenia—Losartan—type 2 diabetes mellitus	0.000139	0.00058	CcSEcCtD
Treprostinil—Vomiting—Metformin—type 2 diabetes mellitus	0.000139	0.000578	CcSEcCtD
Treprostinil—Rash—Metformin—type 2 diabetes mellitus	0.000137	0.000573	CcSEcCtD
Treprostinil—Dermatitis—Metformin—type 2 diabetes mellitus	0.000137	0.000573	CcSEcCtD
Treprostinil—Pruritus—Losartan—type 2 diabetes mellitus	0.000137	0.000571	CcSEcCtD
Treprostinil—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000137	0.000571	CcSEcCtD
Treprostinil—Headache—Metformin—type 2 diabetes mellitus	0.000136	0.00057	CcSEcCtD
Treprostinil—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000136	0.000568	CcSEcCtD
Treprostinil—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000136	0.000566	CcSEcCtD
Treprostinil—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000132	0.000553	CcSEcCtD
Treprostinil—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000131	0.000547	CcSEcCtD
Treprostinil—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000131	0.000547	CcSEcCtD
Treprostinil—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000131	0.000546	CcSEcCtD
Treprostinil—Rash—Irbesartan—type 2 diabetes mellitus	0.00013	0.000541	CcSEcCtD
Treprostinil—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00013	0.000541	CcSEcCtD
Treprostinil—Nausea—Metformin—type 2 diabetes mellitus	0.000129	0.00054	CcSEcCtD
Treprostinil—Headache—Irbesartan—type 2 diabetes mellitus	0.000129	0.000538	CcSEcCtD
Treprostinil—Dizziness—Losartan—type 2 diabetes mellitus	0.000128	0.000534	CcSEcCtD
Treprostinil—Vomiting—Losartan—type 2 diabetes mellitus	0.000123	0.000514	CcSEcCtD
Treprostinil—Nausea—Irbesartan—type 2 diabetes mellitus	0.000122	0.00051	CcSEcCtD
Treprostinil—Rash—Losartan—type 2 diabetes mellitus	0.000122	0.000509	CcSEcCtD
Treprostinil—Dermatitis—Losartan—type 2 diabetes mellitus	0.000122	0.000509	CcSEcCtD
Treprostinil—Headache—Losartan—type 2 diabetes mellitus	0.000121	0.000506	CcSEcCtD
Treprostinil—Asthenia—Ramipril—type 2 diabetes mellitus	0.000119	0.000497	CcSEcCtD
Treprostinil—Pruritus—Ramipril—type 2 diabetes mellitus	0.000117	0.00049	CcSEcCtD
Treprostinil—Nausea—Losartan—type 2 diabetes mellitus	0.000115	0.00048	CcSEcCtD
Treprostinil—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000114	0.000474	CcSEcCtD
Treprostinil—Dizziness—Ramipril—type 2 diabetes mellitus	0.00011	0.000458	CcSEcCtD
Treprostinil—Vomiting—Ramipril—type 2 diabetes mellitus	0.000105	0.00044	CcSEcCtD
Treprostinil—Rash—Ramipril—type 2 diabetes mellitus	0.000105	0.000437	CcSEcCtD
Treprostinil—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000105	0.000436	CcSEcCtD
Treprostinil—Headache—Ramipril—type 2 diabetes mellitus	0.000104	0.000434	CcSEcCtD
Treprostinil—Nausea—Ramipril—type 2 diabetes mellitus	9.86e-05	0.000411	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—CALM1—type 2 diabetes mellitus	3.81e-05	0.00023	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CYBA—type 2 diabetes mellitus	3.81e-05	0.00023	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CAT—type 2 diabetes mellitus	3.79e-05	0.000229	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.77e-05	0.000228	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.75e-05	0.000227	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	3.75e-05	0.000226	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PLAT—type 2 diabetes mellitus	3.73e-05	0.000225	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GHRL—type 2 diabetes mellitus	3.73e-05	0.000225	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.71e-05	0.000224	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GCG—type 2 diabetes mellitus	3.71e-05	0.000224	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CALCA—type 2 diabetes mellitus	3.69e-05	0.000223	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOB—type 2 diabetes mellitus	3.68e-05	0.000223	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—SRC—type 2 diabetes mellitus	3.67e-05	0.000222	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.65e-05	0.00022	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.64e-05	0.00022	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	3.58e-05	0.000217	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTM1—type 2 diabetes mellitus	3.58e-05	0.000216	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—type 2 diabetes mellitus	3.57e-05	0.000216	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TGFB1—type 2 diabetes mellitus	3.56e-05	0.000215	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—LPL—type 2 diabetes mellitus	3.52e-05	0.000213	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.47e-05	0.00021	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.47e-05	0.00021	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.46e-05	0.000209	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ADCY5—type 2 diabetes mellitus	3.44e-05	0.000208	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GPX1—type 2 diabetes mellitus	3.43e-05	0.000207	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.41e-05	0.000206	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GCG—type 2 diabetes mellitus	3.41e-05	0.000206	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.41e-05	0.000206	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.41e-05	0.000206	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.36e-05	0.000203	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.35e-05	0.000202	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CD36—type 2 diabetes mellitus	3.34e-05	0.000202	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PPARG—type 2 diabetes mellitus	3.3e-05	0.0002	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPP2CA—type 2 diabetes mellitus	3.3e-05	0.000199	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TGFB1—type 2 diabetes mellitus	3.28e-05	0.000198	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	3.28e-05	0.000198	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	3.28e-05	0.000198	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.23e-05	0.000195	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—BHMT—type 2 diabetes mellitus	3.21e-05	0.000194	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.2e-05	0.000193	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.19e-05	0.000193	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—MTHFR—type 2 diabetes mellitus	3.17e-05	0.000191	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.15e-05	0.000191	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AVP—type 2 diabetes mellitus	3.15e-05	0.000191	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.14e-05	0.00019	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.14e-05	0.00019	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.14e-05	0.000189	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.13e-05	0.000189	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARA—type 2 diabetes mellitus	3.11e-05	0.000188	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.09e-05	0.000187	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOB—type 2 diabetes mellitus	3.05e-05	0.000184	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.04e-05	0.000183	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AGT—type 2 diabetes mellitus	3.01e-05	0.000182	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EDN1—type 2 diabetes mellitus	3e-05	0.000181	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—SERPINE1—type 2 diabetes mellitus	2.97e-05	0.00018	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.97e-05	0.000179	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CALM1—type 2 diabetes mellitus	2.96e-05	0.000179	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOE—type 2 diabetes mellitus	2.95e-05	0.000178	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.94e-05	0.000178	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOA1—type 2 diabetes mellitus	2.91e-05	0.000176	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LPL—type 2 diabetes mellitus	2.91e-05	0.000176	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AVP—type 2 diabetes mellitus	2.9e-05	0.000175	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.9e-05	0.000175	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.89e-05	0.000175	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.88e-05	0.000174	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.85e-05	0.000172	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.85e-05	0.000172	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AANAT—type 2 diabetes mellitus	2.81e-05	0.00017	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGDS—type 2 diabetes mellitus	2.81e-05	0.00017	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOB—type 2 diabetes mellitus	2.8e-05	0.000169	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.79e-05	0.000169	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.76e-05	0.000167	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.73e-05	0.000165	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.68e-05	0.000162	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LPL—type 2 diabetes mellitus	2.68e-05	0.000162	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	2.67e-05	0.000161	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CDO1—type 2 diabetes mellitus	2.66e-05	0.000161	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GPD2—type 2 diabetes mellitus	2.66e-05	0.000161	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.62e-05	0.000158	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—C3—type 2 diabetes mellitus	2.62e-05	0.000158	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	2.6e-05	0.000157	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	2.59e-05	0.000156	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARG—type 2 diabetes mellitus	2.57e-05	0.000155	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AK1—type 2 diabetes mellitus	2.54e-05	0.000153	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—INS—type 2 diabetes mellitus	2.52e-05	0.000152	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.51e-05	0.000152	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	2.51e-05	0.000152	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.5e-05	0.000151	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.49e-05	0.000151	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AGT—type 2 diabetes mellitus	2.49e-05	0.00015	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—AKT1—type 2 diabetes mellitus	2.48e-05	0.00015	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.47e-05	0.000149	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.45e-05	0.000148	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOE—type 2 diabetes mellitus	2.44e-05	0.000147	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LEP—type 2 diabetes mellitus	2.44e-05	0.000147	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—C3—type 2 diabetes mellitus	2.41e-05	0.000146	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.41e-05	0.000146	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	2.34e-05	0.000142	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	2.34e-05	0.000142	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	2.33e-05	0.000141	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALB—type 2 diabetes mellitus	2.31e-05	0.00014	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.3e-05	0.000139	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.3e-05	0.000139	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.29e-05	0.000139	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AGT—type 2 diabetes mellitus	2.29e-05	0.000138	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	2.29e-05	0.000138	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—AKT1—type 2 diabetes mellitus	2.28e-05	0.000138	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	2.27e-05	0.000137	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	2.26e-05	0.000137	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	2.26e-05	0.000137	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	2.26e-05	0.000137	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	2.26e-05	0.000137	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.26e-05	0.000137	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.25e-05	0.000136	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LEP—type 2 diabetes mellitus	2.24e-05	0.000136	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOE—type 2 diabetes mellitus	2.24e-05	0.000136	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.22e-05	0.000134	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—NOS3—type 2 diabetes mellitus	2.21e-05	0.000133	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3R1—type 2 diabetes mellitus	2.21e-05	0.000133	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	2.19e-05	0.000132	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.18e-05	0.000131	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.12e-05	0.000128	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	2.11e-05	0.000128	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—INS—type 2 diabetes mellitus	2.08e-05	0.000126	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	2.07e-05	0.000125	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	2.07e-05	0.000125	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.05e-05	0.000124	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—type 2 diabetes mellitus	2.02e-05	0.000122	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	2.02e-05	0.000122	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.02e-05	0.000122	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.01e-05	0.000122	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.01e-05	0.000121	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IRS1—type 2 diabetes mellitus	2e-05	0.000121	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	1.92e-05	0.000116	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	1.92e-05	0.000116	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	1.92e-05	0.000116	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—INS—type 2 diabetes mellitus	1.92e-05	0.000116	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.91e-05	0.000116	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.89e-05	0.000114	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.86e-05	0.000112	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.85e-05	0.000112	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.85e-05	0.000112	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	1.85e-05	0.000112	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	1.85e-05	0.000112	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.83e-05	0.00011	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.83e-05	0.00011	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	1.78e-05	0.000107	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	1.78e-05	0.000107	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.76e-05	0.000106	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	1.74e-05	0.000105	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.74e-05	0.000105	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RELA—type 2 diabetes mellitus	1.72e-05	0.000104	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.72e-05	0.000104	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.72e-05	0.000104	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.72e-05	0.000104	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.68e-05	0.000102	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.68e-05	0.000102	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.66e-05	0.0001	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.61e-05	9.75e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.59e-05	9.59e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RELA—type 2 diabetes mellitus	1.58e-05	9.57e-05	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.57e-05	9.46e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.55e-05	9.38e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.55e-05	9.36e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.54e-05	9.31e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	1.51e-05	9.13e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.51e-05	9.12e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.47e-05	8.86e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	1.46e-05	8.81e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	1.46e-05	8.81e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	1.46e-05	8.81e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	1.46e-05	8.81e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.45e-05	8.77e-05	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.44e-05	8.71e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.43e-05	8.63e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.42e-05	8.59e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.42e-05	8.57e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.4e-05	8.48e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	1.4e-05	8.45e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.36e-05	8.21e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SRC—type 2 diabetes mellitus	1.35e-05	8.17e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.35e-05	8.15e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.34e-05	8.07e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.33e-05	8.04e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.32e-05	7.96e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.32e-05	7.95e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.31e-05	7.91e-05	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—AKT1—type 2 diabetes mellitus	1.31e-05	7.89e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	1.3e-05	7.86e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SRC—type 2 diabetes mellitus	1.24e-05	7.52e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	1.21e-05	7.33e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.21e-05	7.32e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.21e-05	7.3e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	1.19e-05	7.19e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	1.19e-05	7.19e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.18e-05	7.16e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1.17e-05	7.05e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.16e-05	7.01e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	1.16e-05	7e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	1.16e-05	7e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	1.16e-05	7e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.15e-05	6.96e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.13e-05	6.83e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.12e-05	6.76e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.11e-05	6.72e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.09e-05	6.59e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.04e-05	6.3e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.04e-05	6.28e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.04e-05	6.28e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.04e-05	6.28e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.02e-05	6.16e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AKT1—type 2 diabetes mellitus	1.02e-05	6.13e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.01e-05	6.11e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.97e-06	6.03e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	9.89e-06	5.98e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	9.51e-06	5.74e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	9.4e-06	5.68e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	9.4e-06	5.68e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	9.17e-06	5.54e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.12e-06	5.51e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—type 2 diabetes mellitus	9.11e-06	5.5e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	9.01e-06	5.45e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	9.01e-06	5.45e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.4e-06	5.08e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—type 2 diabetes mellitus	8.38e-06	5.06e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	7.77e-06	4.69e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.77e-06	4.69e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	7.73e-06	4.67e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.73e-06	4.67e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	7.63e-06	4.61e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	7.41e-06	4.48e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	7.2e-06	4.35e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	7.07e-06	4.27e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	6.92e-06	4.18e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	6.9e-06	4.17e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	6.72e-06	4.06e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	6.63e-06	4.01e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	6.37e-06	3.85e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	6.25e-06	3.77e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	6.05e-06	3.66e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	5.95e-06	3.59e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	5.93e-06	3.58e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	5.86e-06	3.54e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	5.16e-06	3.12e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	5.06e-06	3.06e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	4.64e-06	2.81e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	4.44e-06	2.68e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	4.44e-06	2.68e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	4.06e-06	2.45e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	2.04e-06	1.23e-05	CbGpPWpGaD
